جست‌وجوی استاد و پژوهشگر

Charles Dankoمشاهده پروفایل

دانشیار

• Transcriptional Regulation
• Functional Genomics
• Epigenomics
• +۸ مورد دیگر

Dr. Charles Danko is an Associate Professor at Cornell University College of Veterinary Medicine , affiliated with the Baker Institute for Animal Health and the Department of Biomedical Sciences . His research bridges computational biology and molecular genetics, focusing on how DNA sequences and chromatin structure regulate gene transcription across species and in diseases like cancer. Education : Postdoctoral Fellow, Genomics/Bioinformatics, Cornell University (2009) PhD in Bioinformatics, SUNY Upstate Medical University (2009) BS in Biomedical Engineering, Johns Hopkins University (2003) His work explores the role of gene enhancers in evolution, the transcriptional mechanisms of glioblastoma, and machine learning tools like dREG and dHIT for epigenomic annotation. Recent studies highlight RNA polymerase II dynamics, histone modification prediction, and evolutionary changes in regulatory elements. Scientific Awards : Bausch & Lomb Honorary Science Award (1999) Professional and Public Service Award (2008) Postdoctoral Fellowships (2009, 2010) Best Poster, Reproductive Genomics Retreat (2012) Danko leads an interdisciplinary lab combining computational and molecular techniques, including PRO-seq, Hi-C, and CRISPR epigenome editing. His team investigates how natural genetic mutations and chromatin packaging influence phenotypic differences and disease states, particularly in CD4+ T cells and glioblastoma.

Christian Vaisseمشاهده پروفایل

استاد

• Obesity Genetics
• Molecular Endocrinology
• Neuronal Primary Cilia
• +۳ مورد دیگر

Christian Vaisse, MD, PhD, is a Professor in the Department of Medicine at the University of California San Francisco (UCSF), specializing in obesity genetics and molecular endocrinology. As Principal Investigator on multiple NIH-funded grants (R01DK106404, R01DK060540, P30DK098722, R01DK124769), his research explores how neuronal primary cilia and melanocortin receptors regulate energy homeostasis. He has also contributed to understanding genetic predispositions to obesity through CRISPR-based studies and genomic mapping of leptin-responsive neurons. Education: MD, University of Paris XI (1983-88) PhD, Molecular Endocrinology, University of Paris XI (1988-91) Research Focus: Obesity genetics, melanocortin receptor pathways, cilia-mediated signaling, and translational studies on metabolic disorders. His work bridges molecular mechanisms (e.g., MC4R-ADCY3 complexes) with clinical implications, including therapeutic targets for obesity and diabetes. Scientific Awards: ALFEDIAM/NOVO-NORDISK Post-doctoral research award (1995) Philippe Foundation Post-Doctoral Research Award (1996) INSERM-CR1 tenure (1998) American Diabetes Association-Career Development Award (2000) Greenberg Young Investigator Award in Cardiovascular Genetics NIH Grants: Continuous NIH funding since 2002 for research on the melanocortin-4 receptor, obesity GWAS, and ciliopathies. Collaborative projects include contributions to the UCSF Nutrition Obesity Research Center (P30DK098722) and Diabetes Research Center (P30DK063720).

• Epigenetics
• Cardiovascular Genetics
• Gene Expression Regulation
• +۵ مورد دیگر

Sara Pagans Lista is an Associate Professor in the Department of Medical Sciences at the Faculty of Medicine, University of Girona. She is also a key researcher in the Cardiovascular Genetics Research Group at the Dr. Josep Trueta Biomedical Research Institute (IDIBGI). Her academic leadership extends to university governance, where she currently serves as Vice-Rector for Students, Mobility, and Employment (2021–present), having previously held roles as Academic Secretary and Vice-Dean of the Faculty of Medicine. Education: Licentiate in Biochemistry and Molecular Biology, Autonomous University of Barcelona (1997) PhD in Biochemistry and Molecular Biology, Autonomous University of Barcelona (2003) Her research spans molecular mechanisms of gene regulation, with a current focus on epigenetics in cardiovascular diseases and the role of non-coding genetic variants. Early work explored transcriptional regulation in Drosophila development, followed by postdoctoral research on HIV-1 transcriptional control at the Gladstone Institute (UC San Francisco), where she studied post-translational modifications of the Tat protein. Her recent work integrates epigenomics and proteomics to uncover disease mechanisms in cardiology. The 15 most recent publications reflect a strong trajectory in molecular cardiology and virology, with increasing emphasis on epigenetic and regulatory mechanisms in heart disease. Keywords include epigenetics, gene regulation, cardiovascular genetics, and virology, with subfields ranging from chromatin remodeling to non-coding RNA and metabolic-epigenetic crosstalk. Scientific Recognition: Publication in PLoS Biology highlighted as 'Must Read' by Faculty of 1000 Biology Sara Pagans Lista has served as Principal Investigator on national and European research projects, securing competitive funding to advance her work in cardiovascular epigenetics. She actively mentors researchers within her group and contributes to academic training through teaching in the Medicine and Molecular Biology Master’s programs. She also participates in scientific outreach via the Chair of Scientific Culture and Digital Communication at UdG. She leads research within the Cardiovascular Genetics Research Group at IDIBGI, a multidisciplinary team focused on identifying genetic and epigenetic factors in heart disease. The group employs cutting-edge molecular and genomic techniques to translate basic findings into clinical insights.

Subhash Vermaمشاهده پروفایل

استاد

• Virology
• Microbiology
• Immunology
• +۵ مورد دیگر

Subhash Verma is a Professor in the Department of Microbiology and Immunology at the University of Nevada, Reno School of Medicine. His research focuses on the molecular mechanisms of viral replication, particularly human herpesviruses (KSHV, EBV) and SARS-CoV-2. He investigates viral latency, reactivation, oncogenesis, and the development of antivirals using single-molecule assays, next-generation sequencing, and cell-based models. Education: B.S. in Biology, Dr. RMLA University, India M.D. in Microbiology, Dr. RMLA University, India Ph.D. in Biotechnology, Banaras Hindu University, India Post-Doc, University of Pennsylvania, USA His work spans virology, molecular biology, and biotechnology, with a strong emphasis on host-virus interactions, epigenetic regulation, and eco-friendly disinfection technologies. Recent publications highlight SARS-CoV-2 variants, KSHV latency, and G-quadruplex RNA structures as therapeutic targets. He co-developed ozone-based and photocatalytic viral inactivation systems and functionalized nanotube biosensors. Key trends in his research include Viral genome replication and persistence Angiogenesis in tumor virology Pattern recognition receptors in infection Cytokine dynamics in immunopathology Quorum sensing parallels in microbiology

• Endocrinology
• Diabetes
• Adipose Tissue Research
• +۳ مورد دیگر

Ingrid Dahlman is an Adjunct Professor of Diabetes Research at the Department of Medicine, Huddinge and Senior Consultant in Endocrinology and Diabetology at Ersta Hospital, Stockholm. She is affiliated with the Department of Clinical Science and Education, Södersjukhuset at Karolinska Institutet where she holds an appointment from 2023-2027. Dahlman is also part of the NeuroCardioMetabol Group led by Thomas Nyström & Cesare Patrone, focusing on the intersection of metabolic, cardiovascular, and neurological research. Dahlman's research centers on the role of human abdominal subcutaneous adipose tissue in insulin resistance and type 2 diabetes development. Her work employs global transcriptome and DNA methylome profiling, along with genetic association analyses, to define gene regulatory pathways in adipocytes that contribute to adipose tissue dysfunction. She has identified several key genes including PLXND1 and LAMB3 that regulate body fat size, distribution, and adipose morphology. Her research spans molecular mechanisms of adipose tissue function, genetic determinants of obesity, and clinical aspects of metabolic diseases including post-pancreatitis diabetes. Analysis of her recent publications (2020-2025) reveals a strong focus on adipose tissue biology, particularly examining the molecular mechanisms linking adipose dysfunction to insulin resistance and type 2 diabetes. Her work integrates genetic, epigenetic, and transcriptomic approaches with clinical observations, demonstrating how adipose tissue characteristics influence metabolic health. Recent studies highlight connections between adipose tissue inflammation, lipid metabolism, and insulin signaling pathways, with particular attention to how these mechanisms differ between adipose depots and how they respond to interventions like bariatric surgery. Dahlman has maintained an active research program with numerous collaborative publications in high-impact journals including Nature Communications, Diabetes, and Cell Metabolism. Her work bridges basic molecular research with clinical applications, particularly in understanding the pathophysiology of obesity-related metabolic disorders. As an active researcher and clinician, Dahlman contributes to both academic and clinical aspects of endocrinology and diabetes care. Her dual role as Adjunct Professor and Senior Consultant enables her to translate research findings into clinical practice while maintaining a strong laboratory research program focused on adipose tissue biology and its role in metabolic disease.

• Cell Cycle Regulation
• Mitotic Entry Signaling
• DNA-damage Checkpoints
• +۳ مورد دیگر

Arne Lindqvist is a Principal Researcher and Docent at the Department of Cell and Molecular Biology, Karolinska Institutet, where he leads the research group focusing on cell cycle, mitotic entry, and DNA-damage checkpoints. His work investigates how human cells decide to divide through signaling networks regulating mitotic entry and their interaction with DNA-damage checkpoints. Education: Docent, Karolinska Institutet (2016) PhD in Cell and Molecular Biology, Karolinska Institutet (2005) Dr. Lindqvist's research employs two complementary approaches: investigation of individual protein functions in mitotic regulation, and development of biophysical models to understand system-level behaviors. His group specializes in advanced microscopy techniques to study these processes. Primary research areas include CDK1/PLK1 activation dynamics, DNA replication-checkpoint interactions, and cell cycle exit mechanisms. His publication record (2015-2025) demonstrates consistent focus on cell cycle regulation, with recent work emphasizing CDK1 activation mechanisms, topoisomerase functions during mitosis, and metabolic regulation of cell division. Research consistently integrates molecular biology, biophysics, and advanced imaging approaches. Research Group: Karen Akopyan (Research Specialist) Zhiyu Hao (PhD Student) Funding: Awarded Swedish Cancer Society grant (2025-2027) as part of departmental SEK 40 million funding initiative.

• Genetics
• Genomics and transcriptomics
• Molecular evolution
• +۲ مورد دیگر

Dr. Austen Ganley is a Senior Lecturer at the University of Auckland's School of Biological Sciences, specializing in Genetics , Genomics , and Molecular Evolution . He earned his BSc, BSc(Hons), and PhD in Genetics from Massey University before conducting postdoctoral research at Duke University, National Institute of National Biology (Japan), and National Institute of Genetics (Japan). Education PhD in Genetics (Massey University, 1995-2000) BSc (Honours) in Genetics (Massey University, 1993-1993) BSc in Genetics (Massey University, 1990-1992) His research focuses on genome structure and the evolution of repetitive DNA sequences , particularly ribosomal DNA (rDNA) dynamics. Through experimental evolution in yeast models and genomic analyses of fungi like Epichloë festucae , he investigates mechanisms such as concerted evolution , gene conversion , and nucleolar organization in relation to cellular aging and pathogenic adaptation. Recent publications highlight his work on non-coding transcription in aging, allopolyploid gene expression patterns, and fungal genome architecture . His studies often employ comparative genomics and high-throughput sequencing to uncover conserved eukaryotic responses to genome merger events. Despite extensive collaborations, no specific scientific awards are mentioned in the provided data. As an accredited PhD supervisor , he contributes to training the next generation of researchers. His laboratory work spans institutions in Japan, Denmark, and New Zealand, with technical expertise in phylogenetic footprinting , Hi-C mapping , and homeolog expression analysis .

Ansgar Zochمشاهده پروفایل

استادیار

• Genome defence mechanisms
• piRNA-directed repression of transposons
• Transposable elements
• +۴ مورد دیگر

Dr. Ansgar Zoch is a Chancellor's Fellow and Group Leader at the Institute of Genetics and Cancer, University of Edinburgh. His research focuses on understanding the molecular mechanisms that defend genome integrity in the germline, with particular emphasis on the piRNA pathway and its role in transposon silencing. Dr. Zoch's research interests span several interconnected areas of molecular genetics and epigenetics. His primary focus is on piRNA-directed repression of transposons , which are mobile genetic elements that threaten genome stability. His lab investigates how the piRNA pathway identifies active transposon loci and initiates epigenetic silencing mechanisms, particularly through DNA methylation. This research has direct implications for understanding male infertility , as failures in transposon silencing lead to impaired spermatogenesis in both mice and humans. Using an interdisciplinary approach that bridges molecular interactions to in vivo mouse models, Dr. Zoch's work aims to decipher fundamental mechanisms of gene regulation and transposon-driven pathologies. Analysis of Dr. Zoch's recent publications reveals a consistent focus on the piRNA pathway and its components. His research has made significant contributions to understanding how proteins like C19ORF84, TEX15, and SPOCD1 connect piRNA machinery with DNA methylation systems to defend the germline genome. The publications demonstrate a progression from basic mechanism discovery to clinical implications, particularly in understanding the genetic basis of human male infertility. His work increasingly integrates structural biology, epigenetics, and reproductive medicine to provide a comprehensive view of genome defense mechanisms. Dr. Zoch currently leads an active research project titled "Understanding piRNA-guided transcriptional repression," funded by the Royal Society from October 2024 to September 2025. His laboratory employs advanced techniques including mouse genetics and transgenesis, immunoprecipitation-mass spectrometry (IP-MS), and whole genome DNA methylation analysis to investigate genome defense mechanisms. The Zoch Research Group operates within the Institute of Genetics and Cancer at the University of Edinburgh, contributing to the institution's strong reputation in genetics and molecular biology research. The group collaborates extensively with other researchers both within the university and internationally, as evidenced by the multi-institutional nature of his publications.

Catherine Abbottمشاهده پروفایل

استاد

• Cancer Biology
• Neuroscience
• Genetics
• +۳ مورد دیگر

Professor Catherine Abbott is a faculty member at the University of Edinburgh, based at the Centre for Genomic and Experimental Medicine within the MRC Institute of Genetics and Molecular Medicine. She serves as Director of the IGMM Graduate School, overseeing a 4-year PhD program in genomic and experimental medicine. Her academic qualifications include a Bachelor of Science in Pathobiology (2:1) from the University of Reading (1983) and a PhD in Biochemical Genetics from the MRC Mammalian Genetics Unit, Harwell (1987). Following postdoctoral research at University College London's Galton Laboratory, she held a lectureship at UCL before joining the University of Edinburgh in 1993. Professor Abbott's research spans cancer biology and neuroscience , with focus on molecular mechanisms of neurodevelopmental disorders and breast cancer. Her work centers on translation elongation factors—particularly eEF1A2—using mouse models to investigate disease pathogenesis in intellectual disability, epilepsy, and oncogenesis. Her laboratory employs advanced genetic, molecular, and imaging techniques to dissect pathological pathways . Analysis of her recent publications (2020-2025) reveals dominant themes: EEF1A2-related neurodevelopmental disorders (including mouse model development and genotype-phenotype studies), therapeutic interventions (AAV9 gene therapy), and cancer mechanisms (eEF1A2-PTEN-GSK3β-Aurora kinase A pathway in breast cancer). Her work bridges fundamental molecular biology with clinical translation. As Director of the IGMM Graduate School, Professor Abbott leads postgraduate education and supervision for over 100 PhD students annually. Her research group collaborates with clinical geneticists and neuroscientists across the UK and Europe, securing sustained funding for translational projects in genomic medicine. The Centre for Genomic and Experimental Medicine—where her laboratory is housed—forms part of Edinburgh's globally recognized MRC Institute of Genetics and Molecular Medicine, providing state-of-the-art facilities for genomic sequencing, mouse phenotyping, and neurophysiological analysis.

Olaf Wolkenhauerمشاهده پروفایل

استاد

• Systems Biology
• Bioinformatics
• Machine Learning
• +۵ مورد دیگر

Olaf Wolkenhauer is a Full Professor and Chair in Systems Biology & Bioinformatics at the Faculty of Computer Science & Electrical Engineering, University of Rostock, a position he has held since 2003. Additionally, he serves as Guest Professor and Interim Head of Section III at the Leibniz Institute for Food Systems Biology, Technical University of Munich, until 2025. He maintains adjunct professorships at Chhattisgarh Swami Vivekanand Technical University (India) and Case Western Reserve University (USA). His research integrates data science and mathematical modeling to decipher emergent properties in cellular systems, combining data-driven and model-driven approaches. Utilizing machine learning, statistics, systems theory, and stochastic processes, he investigates how interactions between cellular components produce system-level functions that constrain part behaviors. His work bridges computational sciences with life sciences applications in biomedical research, pharmaceutical development, and clinical decision support. Recent publications reveal dominant themes in cancer systems biology (melanoma, metastasis), network analysis of high-throughput data, drug repositioning, and computational methods for imbalanced datasets. Key interdisciplinary applications include SARS-CoV-2 virus-host interaction mapping, inflammation resolution mechanisms, and E2F1 transcription factor networks in therapeutic resistance. Scientific recognition includes: SPIE Pioneer Award (2009) IBM Computing Prize (1994) Wolkenhauer leads collaborative projects with biomedical researchers, pharmaceutical companies, and IT firms, developing machine learning workflows for wet-lab data analysis, molecular network modulation studies, and clinical decision support systems. His teaching includes graduate courses in BioSystems Modelling, Life Sciences Simulation, and Python-based Data Science. He directs the Research Group Network Regulation & Modeling / Machine Learning at the Leibniz Institute, contributing to major initiatives like the COVID-19 Disease Map and Atlas of Inflammation Resolution, fostering international networks in systems medicine and computational biology.

• Cancer
• Breast Cancer
• Molecular Biology
• +۴ مورد دیگر

Dinny Graham is a Senior Research Fellow at the Westmead Clinical School , University of Sydney. A distinguished cancer researcher, Graham's work focuses on breast cancer and nuclear receptor signaling , particularly progesterone and mineralocorticoid receptors . Their research integrates molecular biology and computational biology to unravel hormone-driven cancer mechanisms. Research Themes : Cancer, Breast Cancer, Computational Biology Approaches : Cellular/Molecular, Receptor Biology Recent publications analyze cancer subtyping via federated deep learning , the mineralocorticoid receptor's role in oncogenesis, and AI-based pathology scoring for triple-negative breast cancer. Graham's team explores drug delivery systems and metabolic reprogramming in clinical contexts. Honorifics include grants from NSW Health , Cancer Institute NSW , and Tour de Cure Ltd . Current research students— Rafia ALI , Mona MIRZAEIMILANI , and Yiting WANG —investigate biomimetic nanoparticles, EMT-immunotherapy interactions, and drug response modeling.

• Animal Breeding
• Genetics
• Genomics
• +۷ مورد دیگر

Ole Madsen is an Associate Professor at Wageningen University & Research, specifically within the Wageningen Institute of Animal Sciences (WIAS) and the Department of Animal Breeding and Genetics. His research focuses on advanced animal breeding techniques, genomics, and epigenetics in livestock species, particularly pigs and sheep. Research Focus: His work spans a wide range of topics including gene expression, transcriptomics, genomics, epigenetics, and DNA methylation. He is particularly interested in understanding the genetic basis of complex traits in livestock and applying this knowledge to improve animal breeding programs. Recent Research Trends: His recent publications indicate a strong focus on integrating genomic and epigenomic approaches to understand trait variation in pigs and sheep. This includes studies on long non-coding RNAs, archaeogenomic analyses of pig domestication, and the effects of nutritional interventions on epigenetic regulation and animal performance. Scientific Awards: While no specific awards are listed in the provided text, his extensive publication record (133 outputs) and active role in supervising PhD students and leading research projects indicate significant contributions to the field. Supervision and Projects: He currently supervises multiple PhD students including H. Fotowatikha Someeserai, Z. Zhuang, P. da Costa Sa, W. Yao, and L. Deng. His active projects cover areas such as regulatory element annotation, semen trait epigenetics, genome introgression, and multi-omics analysis for meat quality traits. Collaborations: His work involves extensive international collaborations, as evidenced by co-authorship on papers with researchers from various countries. He is also involved in the FAANG (Functional Annotation of Animal Genomes) initiative.

• Genomics
• Genetics
• Animal Breeding
• +۵ مورد دیگر

M.A.M. Groenen is a Professor in the Department of Animal Breeding and Genetics at Wageningen University and Research. As an active academic, he leads the Wageningen Institute of Animal Sciences (WIAS) research group and serves as promotor for multiple PhD candidates. His affiliation includes roles as an external employee at WIAS, focusing on advanced genomic studies. Research interests span genomics , genetics , and animal breeding , with emphasis on: Genetic divergence and population genomics Whole-genome sequencing applications in livestock Genotyping methodologies and gene expression analysis Breed-specific trait optimization in horses, pigs, and poultry Recent publications (2025) demonstrate concentrated work in livestock genomics , including comparative methylation analysis, mutation rate characterization, and genome-wide association studies across swine, equine, and bovine species. These reflect a consistent focus on translating genomic data into breeding solutions. Professor Groenen leads 41 research projects, including active initiatives like GENOPRRS (decoding host-pathogen genomics) and ConserFriesian (genetic conservation of horse breeds). He has supervised 37 academic works and engages extensively in scientific dissemination through lectures and conferences.

Zheng-Gen Jinمشاهده پروفایل

استاد

• Molecular Regulation of Vascular Endothelial Function
• Atherosclerosis
• Endothelial Dysfunction
• +۷ مورد دیگر

Zheng-Gen Jin, Ph.D., is a Professor in the Department of Medicine at the University of Rochester Medical Center's School of Medicine and Dentistry. He is a principal investigator at the Aab Cardiovascular Research Institute and affiliated with the Center for Inhalation and Flavoring Toxicological Research (CIFT) and the Ph.D. Program in Cellular and Molecular Pharmacology and Physiology. Department: Department of Medicine Institution: University of Rochester Medical Center Research Institute: Aab Cardiovascular Research Institute Additional Affiliation: Center for Inhalation and Flavoring Toxicological Research (CIFT) Dr. Jin's primary research focuses on the molecular regulation of vascular endothelial function , particularly how hemodynamic forces like laminar shear stress and pathological stimuli such as oxidative stress regulate endothelial nitric oxide synthase (eNOS), inflammation, and atherosclerosis. His work investigates signaling pathways that control endothelial homeostasis and dysfunction, with a strong emphasis on epigenetic mechanisms , including histone deacetylases (HDACs), sirtuins, and non-coding RNAs. He explores how these pathways influence gene expression in response to mechanical and biochemical cues, aiming to develop novel therapeutic strategies for vascular diseases. The 15 most recent publications reflect a consistent focus on endothelial signaling, epigenetics, and atherosclerosis . Key themes include the role of mechanosensitive transcription factors (e.g., KLF2, YY1), chromatin-modifying enzymes (e.g., HDAC5, SIRT6), and non-coding RNAs in vascular protection and disease. The research spans basic molecular mechanisms to potential pharmacological interventions, including natural compounds and HDAC inhibitors. Articles frequently appear in high-impact journals in cardiovascular science, molecular biology, and pharmacology. Dr. Jin leads an active research laboratory with postdoctoral fellows and research staff. His lab is dedicated to uncovering the molecular underpinnings of endothelial function and translating these findings into therapeutic approaches for atherosclerotic vascular diseases. Dr. Jin mentors postdoctoral scholars and research staff, including Gourango Pradhan (Postdoctoral Fellow), Joseph Cain (Research Technician), Ismail Cimen (Staff Scientist), and Rebbeca Steiner (Research Specialist). While formal PhD or Master’s students are not listed, his lab provides training and research opportunities in vascular biology and molecular signaling.

Zhen Bouman Chenمشاهده پروفایل

دانشیار

• Epigenetic Regulation
• Endothelial Biology
• Cardiovascular Diseases
• +۷ مورد دیگر

Zhen Bouman Chen, Ph.D. is an Associate Professor in the Department of Diabetes Complications & Metabolism at City of Hope's Beckman Research Institute. She directs a research team focused on RNA-mediated endothelial biology in diabetes and related complications, integrating high-throughput sequencing, bioinformatics, and multi-scale modeling approaches. Her educational background includes: 2021: Certificate in Data Science and Visualization from UC San Diego Extension 2010: Ph.D. in Biomedical Sciences from University of California Riverside 2005: B.S. in Basic Medical Sciences from Peking University Health Science Center, China Dr. Chen's research centers on epigenetic regulation in endothelial stress response and its translational relevance to cardiovascular diseases. Her work bridges medicine, vascular biology, bioengineering, and data science to understand RNA-mediated mechanisms in diabetes complications. She employs innovative approaches including high-throughput sequencing and bioinformatics to investigate endothelial biology in diabetic conditions, with particular focus on non-coding RNAs, epitranscriptional regulation, and vascular dysfunction mechanisms. Her recent publications reveal consistent themes across cardiovascular biology, diabetes complications, and RNA regulation. The research shows increasing sophistication in single-cell approaches, multi-omics integration, and translational applications targeting vascular complications in metabolic disease. Key trends include exploration of long non-coding RNAs in vascular dysfunction, mitochondrial-nuclear communication in endothelial cells, and novel therapeutic approaches for diabetic vasculopathy. Notable scientific recognition includes: National Heart, Lung, and Blood Institute R35 Emerging Investigator Award (2024) Chinese American Diabetes Association Young Investigator Award (2023) Springer Junior Investigator Award from NAVBO (2020) New Investigator Award from American Physiological Society (2018) K99 Career Development Award from NIH (2014) Dr. Chen has successfully secured research funding from multiple prestigious sources including NIH, American Heart Association, Chan Zuckerberg Foundation, and Ella Fitzgerald Foundation. She actively mentors students and postdocs while serving in leadership roles, including as Chair of the Women's Leadership Committee of the Arteriosclerosis, Thrombosis, and Vascular Biology Council of the American Heart Association. Her commitment to mentorship extends to coaching Science Olympiads at local middle schools. She leads a dynamic research team within the Diabetes Complications and Metabolism research program at City of Hope, focusing on molecular and cellular biology approaches to understand and treat vascular complications of diabetes.